tetano
Editor, Senior Moderator
Neurol Clin
. 2024 May;42(2):507-520.
doi: 10.1016/j.ncl.2023.12.006. Epub 2024 Jan 12. Headache Associated with Coronavirus Disease 2019
Pedro Augusto Sampaio Rocha-Filho[SUP] 1 [/SUP]
Affiliations
Headache affects around half of patients in the acute phase of COVID-19 and generally occurs at the beginning of the symptomatic phase, has an insidious onset, and is bilateral, and of moderate to severe intensity. COVID-19 may also present complications that cause acute and persistent headaches, such as cerebrovascular diseases, rhinosinusitis, meningitis, and intracranial hypertension. In 10% to 20% of patients with COVID-19, headache may persist beyond the acute phase. In general, the headache improves over time. To date, there are no clinical trials that have assessed the treatment of persistent post-COVID-19 headache.
Keywords: COVID-19; Disease management; Headache; Headache disorders; New daily persistent headache; Physiopathology; Post-acute COVID-19 syndrome; Secondary.
. 2024 May;42(2):507-520.
doi: 10.1016/j.ncl.2023.12.006. Epub 2024 Jan 12. Headache Associated with Coronavirus Disease 2019
Pedro Augusto Sampaio Rocha-Filho[SUP] 1 [/SUP]
Affiliations
- PMID: 38575263
- DOI: 10.1016/j.ncl.2023.12.006
Headache affects around half of patients in the acute phase of COVID-19 and generally occurs at the beginning of the symptomatic phase, has an insidious onset, and is bilateral, and of moderate to severe intensity. COVID-19 may also present complications that cause acute and persistent headaches, such as cerebrovascular diseases, rhinosinusitis, meningitis, and intracranial hypertension. In 10% to 20% of patients with COVID-19, headache may persist beyond the acute phase. In general, the headache improves over time. To date, there are no clinical trials that have assessed the treatment of persistent post-COVID-19 headache.
Keywords: COVID-19; Disease management; Headache; Headache disorders; New daily persistent headache; Physiopathology; Post-acute COVID-19 syndrome; Secondary.